US3723032062
US3723032062
Genmab A/S
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 22.79B EUR | 1.69B EUR | 1.65B EUR | 1.9B EUR |
Enterprise Value | 25.29B EUR | 5.46B EUR | 5.48B EUR | 5.61B EUR |
Valuation Multiples | ||||
Trailing P/E | 29.19x | 2.14x | 2.01x | 2.47x |
Forward P/E | 24.31x | -- | -- | -- |
Price to Sales | 5.52x | 0.41x | 0.42x | 0.63x |
Price to Book | 3.72x | 0.28x | 0.29x | 0.32x |
EV/Revenue | 6.12x | 1.32x | 1.4x | 1.87x |
EV/EBITDA | 18.36x | 3.5x | 3.68x | 4.59x |
Price to FCF (P/FCF) | 26.18x | 1.94x | 1.89x | 2.17x |
EV/FCF | 29.04x | 6.29x | 6.28x | 6.42x |
FCF Yield | 3.82% | 51.43% | 52.94% | 46.07% |